Investors
Company Overview
RYAH™ is a global technology company focused on Big Data generated by its IoT ecosystem of connected devices (Smart Inhalers™ and Smart Patches™) and Apps uniquely enabling valuable AI-powered predictive analytics of the efficacy of plant-based remedies including cannabis, and other drugs or nutraceuticals.
RYAH Company Highlights
Innovative IoT Ecosystem
Smart Inhalers and Patches and connected Apps, delivering cannabinoids, psychedelics, and other healthy solutions
ISO 13485 Medical Device Certification
First cannabis delivery device certified for hardware and software.
Certifications in Canada, NZ, and soon in EU, UK, and Australia
First AI Patent In Cannabis Industry
U.S. Patent #10,296,714 Granted: Method and system for medical cannabinoid treatment and product selection. July 2019
RYAH MD™ Subscription Service
Enables doctors to monitor and recommend THC and CBD dosing for dry herb vaporization
RYAH Granted Utility Patent For Its Smart Medical Inhaler System
U.S. patent number 15/924,172 "Electronic Vaporizer with Remote Control Capability"
Selected as The Delivery Device For The World’s Largest Cannabis Trial
5 year, 5,000 patient clinical trial in the UK
150 million people regularly use cannabis
Why We’re Different
RYAH Investor Information
RYAH Group is listed on the Canadian Securities Exchange under the symbol “RYAH”
The Company has two classes of shares issued and outstanding: Super Voting and Subordinate Voting shares. The 717,486 Class B Super Voting shares were issued for SEC and IRS regulation purposes and do not trade publicly. The Class B shares can be converted into 71,748,600 Class A Subordinate Voting shares on the basis of 100 Class A Subordinate Voting shares for each Class B share tendered.
Currently there are 448,131,390 Class A shares issued and outstanding.
Investor Frequently Asked Questions
How can I invest in RYAH?
RYAH Group shares trade on the Canadian Securities Exchange (the ''CSE'') symbol: ''RYAH''.
It also trades on the Pink Sheets symbol:''RYAHF''.
You can purchase RYAH Group shares through a registered broker-dealer of your choice.
Occasionally, the Company raises funds through private placements. In such a case, Accredited Investors can purchase shares directly from the Company. If this is of interest to you, please contact RYAH and we will determine if you qualify and keep you informed as to the availability of such placements.
To buy shares, you can either go through an investment advisor or use an online brokerage account from any financial institution in your country.
You should consult a financial professional to determine the risks and suitability of such an investment for you.
What is RYAH’s capital structure?
There are:
519,879,990 shares issued and outstanding
163,570,637 warrants available at different exercise prices
22,324,875 options exercisable at different prices
What is RYAH Group’s Fiscal Year?
Our fiscal year end is December 31.
Does RYAH have any patents granted?
Yes
U.S. Patent #15,924,172: Electronic Vaporizer with Remote Control Capability.
U.S. Patent #10,296,714: Method and system for medical cannabinoid treatment and product selection.
News and Events
News Releases
Events
Are you interested in investing in RYAH?
We are happy to speak, answer questions, discuss opportunities, and/or send you a copy of our Investor Deck.